Search Results

Results 1 - 10 of 18 for stem cells. (3.63 seconds)
  • One treatment improves vaccine response

    Those with aging immune systems struggle to fight off novel viruses and respond weakly to vaccination. Stanford Medicine researchers were able to revitalize the immune system in mice.

  • Drug boosts nerve growth, muscle strength

    A drug that boosts strength in injured or aging mice restores connections between nerves and muscle and suggests ways to combat weakness in humans due to aging, injury or disease.

  • Synthetic biology and sustainability

    Scientists gathered to discuss the future of synthetic biology and how it can help curb climate change and promote sustainability.

  • How beneficial fats increase lifespan

    Fat from olive oil and nuts boosts the numbers of two key cellular structures and protects membranes from damage, lengthening the lives of laboratory worms, Stanford Medicine-led study finds.

  • Leaders pledge to address climate change

    A roundtable at the White House on reducing the health care industry’s climate-warming emissions includes leaders from Stanford Medicine.

  • Bioethicists support researchers

    In the five decades since the emergence of recombinant DNA technology, researchers at Stanford Medicine have benefited from the close involvement of bioethics experts.

  • Lab coat ceremony for new PhD students

    Biosciences PhD students began their careers at Stanford School of Medicine with crisp new lab coats, advice on graduate school success and warm words about the value of discovery.

  • Step toward growing organs

    Researchers have shown initial viability of an embryo that contains both chimpanzee and macaque cells in a preliminary study that explores the feasibility of primate organ genesis.

  • Keto and Mediterranean good for diabetes

    In a trial of the two low-carb diets, both were similarly effective in controlling blood glucose. Keto’s more severe carb restrictions did not provide additional overall health benefits.

  • Targeting enzyme that fuels cancer cells

    Stanford Medicine researchers have created a molecule that blocks an enzyme thought to be instrumental in causing colon cancer relapse or chemotherapy resistance.